| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/29/2003 | US6599499 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 07/29/2003 | US6599498 Enhanced magnetic resonance imaging agent and a hematinic agent; carboxyalkylated reduced polysaccharides coated ultrasmall superparamagnetic iron oxides; carboxymethyl reduced dextran as a plasma extender |
| 07/29/2003 | US6599283 Method of preventing reperfusion injury |
| 07/29/2003 | US6598603 Method for treating respiratory diseases |
| 07/29/2003 | CA2473102A1 Suppression of cytotoxic protein conformers |
| 07/29/2003 | CA2269745C Improved treatment of migraine headache |
| 07/29/2003 | CA2268437C Naringin and naringenin as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor |
| 07/29/2003 | CA2262268C Method of treating impotence due to spinal cord injury |
| 07/29/2003 | CA2244621C 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists |
| 07/29/2003 | CA2189474C Compositions having antiviral properties and preparation process |
| 07/29/2003 | CA2188690C Selective thrombin inhibitors |
| 07/29/2003 | CA2188030C Use of bisphophonates for inhibiting bone resorption following implantation of orthopedic prosthesis |
| 07/29/2003 | CA2180119C The composition containing snapping turtle and tortoise, the preparation and the use thereof |
| 07/29/2003 | CA2132982C Catalytic antibodies against cocaine and methods of using and producing same |
| 07/29/2003 | CA2123514C Novel benzothiophene derivative |
| 07/29/2003 | CA2114136C Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them |
| 07/29/2003 | CA2111900C Ractopamine for pre-and peripubertal female bovidae |
| 07/29/2003 | CA2102530C Therapeutic agent |
| 07/29/2003 | CA2094280C A method for transplanting cells into the brain and therapeutic uses therefor |
| 07/29/2003 | CA2093664C Modified ribozymes |
| 07/29/2003 | CA2078379C Method of treating immunoinflammatory disease |
| 07/29/2003 | CA2076555C Pharmaceuticals for the treatment of rejection reactions in organ transplantations |
| 07/29/2003 | CA2066332C Substituted 3-(pyridinylamino)-indoles and benzo¬b|thiophenes, a process for their preparation and their use as medicaments |
| 07/29/2003 | CA2060489C Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 07/29/2003 | CA2057747C Contraceptive regimen |
| 07/29/2003 | CA2056345C Optically active pyridobenzoxazine derivatives |
| 07/29/2003 | CA2056065C Preparation of 3-alkylated indoles |
| 07/29/2003 | CA2054473C Novel 3-cycloalkyl-propanamides, their tautomers and salts, process for their preparation, application as medicines and compositions containing them |
| 07/29/2003 | CA2050812C Pregna-1,4-diene-3,20-dione-16-17-acetal-21 esters, process for their preparation, compositions, and methods for the treatment of inflammatory conditions |
| 07/29/2003 | CA2048959C 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives |
| 07/28/2003 | CA2398226A1 Increased-dosage nelfinavir tablet and method of making same |
| 07/24/2003 | WO2003060799A2 Compositions for treatment of central nervous system neoplasms, and methods of making and using the same |
| 07/24/2003 | WO2003060475A2 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
| 07/24/2003 | WO2003060468A2 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease |
| 07/24/2003 | WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | WO2003060142A2 Compositions and methods for controlled release |
| 07/24/2003 | WO2003060096A2 Assay for the detection of factors that modulate the expression of ingap |
| 07/24/2003 | WO2003060085A2 Mammalian neural stem cells, compositions and uses thereof |
| 07/24/2003 | WO2003060082A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 07/24/2003 | WO2003060067A2 P85-alpha nucleic acids, polypeptides and related methods |
| 07/24/2003 | WO2003060034A1 Anion generating material and skin treating agent using the same |
| 07/24/2003 | WO2003059987A1 Multidrop tree branching functional polyethylene glycol, the preparation method and the use of it |
| 07/24/2003 | WO2003059973A2 Block copolymers |
| 07/24/2003 | WO2003059951A2 Novel anti-igf-ir antibodies and uses thereof |
| 07/24/2003 | WO2003059940A1 Biomolecule transduction motif sim-2-btm and the use thereof |
| 07/24/2003 | WO2003059927A1 Compositions and methods relating to endometrial specific genes and proteins |
| 07/24/2003 | WO2003059924A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 07/24/2003 | WO2003059921A1 Mmp inhibitors |
| 07/24/2003 | WO2003059913A1 Roh-kinase inhibitors |
| 07/24/2003 | WO2003059912A1 Oxothieno (3, 2-b) pyridinecarboxamides as antiviral agents |
| 07/24/2003 | WO2003059911A2 4-OXO-4, 7-DIHYDROFURO[2,3-b]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS |
| 07/24/2003 | WO2003059906A1 Prucalopride-n-oxide |
| 07/24/2003 | WO2003059905A1 Pyrrolidone carboxamides |
| 07/24/2003 | WO2003059900A1 Coumarin derivatives, process for their production and use thereof |
| 07/24/2003 | WO2003059899A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| 07/24/2003 | WO2003059898A2 Eponemycin and epoxomicin analogs and uses thereof |
| 07/24/2003 | WO2003059895A1 Halogenobenzyl aminopropionic acid derivatives |
| 07/24/2003 | WO2003059894A1 Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them. |
| 07/24/2003 | WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | WO2003059891A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | WO2003059889A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/24/2003 | WO2003059886A1 Acyl sulfonamide derivative |
| 07/24/2003 | WO2003059885A1 Therapeutic acridone and acridine compounds |
| 07/24/2003 | WO2003059884A1 Modulators of lxr |
| 07/24/2003 | WO2003059883A1 (4-oxopiperidin-1-yl)benzoic acid derivatives and process for their preparation |
| 07/24/2003 | WO2003059882A1 Phenoxy piperidines for treating diseases such as schizophrenia and depression |
| 07/24/2003 | WO2003059881A2 Dna minor groove binding compounds |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/24/2003 | WO2003059875A2 DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION |
| 07/24/2003 | WO2003059874A2 Aromatic thioether liver x-receptor modulators |
| 07/24/2003 | WO2003059873A1 Potassium channel modulators |
| 07/24/2003 | WO2003059872A1 Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins |
| 07/24/2003 | WO2003059871A1 N-alkylsulfonyl-substituted amide derivatives |
| 07/24/2003 | WO2003059868A1 Amidoacetonitrile derivatives |
| 07/24/2003 | WO2003059864A2 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 07/24/2003 | WO2003059855A1 Synthesis of combretastatin a-2 prodrugs |
| 07/24/2003 | WO2003059807A2 Crystalline solids of carvedilol and processes for their preparation |
| 07/24/2003 | WO2003059404A2 Preparation for wound healing and prevention of bandage adhesion to the wound |
| 07/24/2003 | WO2003059397A2 Labeling targeting agents with gallium-68 and gallium-67 |
| 07/24/2003 | WO2003059395A2 Antisense compounds directed against human csf-1 |
| 07/24/2003 | WO2003059393A1 Pantoprazole cyclodextrin inclusion complexes |
| 07/24/2003 | WO2003059389A1 Medicinal compositions for improving oral absorption |
| 07/24/2003 | WO2003059388A1 Formulations of quinapril and related ace inhibitors |
| 07/24/2003 | WO2003059384A1 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
| 07/24/2003 | WO2003059382A2 Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression |
| 07/24/2003 | WO2003059378A2 Combined use of a glp-1 compound and another drug for treating dyslipidemia |
| 07/24/2003 | WO2003059377A1 Treatment for intracranial tumors |
| 07/24/2003 | WO2003059373A2 Compositions and their use for enhancing and inhibiting fertilization |
| 07/24/2003 | WO2003059372A2 Combined use of a glp-1 compound and a modulator of diabetic late complications |
| 07/24/2003 | WO2003059371A1 Anti-bacterial plant compositions |
| 07/24/2003 | WO2003059369A1 Lower alcohol-insoluble extract of hovenia dulcis thunb and a polysaccharide isolated therefrom |
| 07/24/2003 | WO2003059361A1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium |
| 07/24/2003 | WO2003059360A1 Novel cholesterol absorption lowering agents |
| 07/24/2003 | WO2003059359A1 D-tagatose as an anti-biofilm agent |
| 07/24/2003 | WO2003059358A1 25-hydroxy vitamin d3 compositions |
| 07/24/2003 | WO2003059357A1 Pregnane steroids for use in the treatment of cns disorders |
| 07/24/2003 | WO2003059355A1 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 07/24/2003 | WO2003059354A2 Anti-angiogenesis combination therapies comprising pyridazine or pyridine derivatives |
| 07/24/2003 | WO2003059353A1 Tyrosyl derivatives and their use as p2x7 receptor modulators |
| 07/24/2003 | WO2003059352A2 Use of a novel class of drugs for the treatment of parasitic diseases |